Neuromuscular Disorders Associated With COVID-19

Area of Science:

• Neurology
• Infectious Diseases
• Critical Care Medicine

Background:

• The COVID-19 pandemic has significantly affected individuals with pre-existing neuromuscular disorders.
• SARS-CoV-2 infection presents a wide spectrum of neuromuscular complications, extending beyond respiratory symptoms.
• Understanding these neurological sequelae is crucial for patient management and prognosis.

Purpose of the Study:

• To review the multifaceted relationship between COVID-19 infection and the neuromuscular system.
• To catalog and discuss various neuromuscular complications associated with SARS-CoV-2.
• To highlight the impact of COVID-19 on patients with pre-existing neuromuscular conditions.

Main Methods:

• Literature review synthesizing current knowledge on COVID-19 and neuromuscular disorders.
• Analysis of documented cases and clinical observations.
• Discussion of pathological mechanisms linking SARS-CoV-2 to neuromuscular system dysfunction.

Main Results:

• COVID-19 is associated with direct and indirect neuromuscular complications.
• Reported conditions include critical illness neuromyopathy, peripheral nerve palsies, myalgias, and positional compressive neuropathies.
• Exacerbation of pre-existing conditions like myasthenia gravis and Guillain-Barré syndrome are observed.

Conclusions:

• COVID-19 poses significant risks to the neuromuscular system in both infected individuals and those with prior neuromuscular disorders.
• Comprehensive understanding and recognition of these diverse neurological manifestations are essential.
• Further research is needed to elucidate long-term neuromuscular outcomes and optimize treatment strategies.